Literature DB >> 1941390

Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children.

J T Wilson1, R D Brown, G L Kearns, V F Eichler, V A Johnson, K M Bertrand, B A Lowe.   

Abstract

Ibuprofen was evaluated as an antipyretic agent in 178 children (aged 3 months to 12 years) to compare dosage (5 vs 10 mg/kg), establish absolute efficacy (with a placebo control group), determine relative efficacy (ibuprofen vs acetaminophen), evaluate maximum efficacy, and identify potential confounding variables. Ibuprofen 5 mg/kg was minimally effective in children less than 6 years of age who had an initial temperature of at least 38.8 degrees C (101.9 degrees F). Ibuprofen 10 mg/kg was more effective for febrile children. The area under the curve for temperature (or change in temperature) captured the net effect of each drug and provided the best estimate for efficacy comparison during a defined period. A linear correlation between initial temperature and measures of efficacy was observed. A twofold increase in efficacy was observed for children with an initial temperature less than 38.8 degrees C. A similar effect was noted for each treatment group. Age was also found to have confounding effects on antipyretic response. A complex interaction between antipyretic response, initial temperature, and age raises questions about the pharmacodynamics of the antipyretic response. We conclude that the most important variable in antipyretic study design is initial temperature. The influence of initial temperature on the magnitude of the response to an antipyretic drug is a previously unappreciated finding with potential impact on pharmacodynamic investigations of antipyretic medications. We describe this finding as nonlinear pharmacodynamics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941390     DOI: 10.1016/s0022-3476(05)80307-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Paracetamol or ibuprofen in febrile children.

Authors:  S Carley
Journal:  J Accid Emerg Med       Date:  1999-03

Review 2.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.

Authors:  B J Anderson; G A Woollard; N H Holford
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

4.  Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever.

Authors:  E Autret; J Reboul-Marty; B Henry-Launois; C Laborde; S Courcier; J M Goehrs; G Languillat; R Launois
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

Review 5.  When a randomised controlled trial is needed to assess drug safety. The case of paediatric ibuprofen.

Authors:  A A Mitchell; S M Lesko
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

6.  Antipyretic effects of nimesulide, paracetamol and ibuprofen-paracetamol.

Authors:  A Lal; S Gomber; B Talukdar
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

Review 7.  Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months.

Authors:  Victoria C Ziesenitz; Andreas Zutter; Thomas O Erb; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

8.  Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children.

Authors:  R D Brown; G L Kearns; J T Wilson
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

Review 9.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

Review 10.  Paracetamol for treating fever in children.

Authors:  M Meremikwu; A Oyo-Ita
Journal:  Cochrane Database Syst Rev       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.